Immunexpress Inc.’s Post

View organization page for Immunexpress Inc., graphic

1,844 followers

Healthcare providers, how are you addressing the shortage in BD BACTEC blood culture media bottles? The FDA recommends prioritizing the use of blood cultures for patients with clinical signs of a bloodstream infection. SeptiCyte® RAPID, a sepsis diagnostic test, has been approved by the FDA to differentiate #sepsis from non-infectious SIRS directly from blood within 60 minutes. SeptiCyte® RAPID can directly support preserving blood culture media for patients at high sepsis risk during this critical supply shortage. Learn more: https://bit.ly/4e6AC5N

  • No alternative text description for this image
Richard Brandon

Developing rapid sepsis diagnostics called SeptiCyte RAPID and RAPID+

3mo

SeptiCyte RAPID scores correlate to likelihood of blood culture positivity. No need to take blood cultures from patients with low scores.

Like
Reply

To view or add a comment, sign in

Explore topics